Institute of Primary Care, University of Zurich and University Hospital Zurich, Zurich, Switzerland
Institute of Primary Care, University of Zurich and University Hospital Zurich, Zurich, Switzerland.
BMJ Open. 2021 May 27;11(5):e049872. doi: 10.1136/bmjopen-2021-049872.
To study the implementation of a cluster randomised controlled effectiveness-implementation hybrid trial testing the effectiveness of a medication review at hospital discharge combined with a communication stimulus between hospital physicians (HPs) and general practitioners (GPs) on rehospitalisation of multimorbid older patients.
Extension of Grant's mixed method process evaluation framework to trials with multilevel clustering.
General internal medicine wards in Swiss hospitals.
Convenience samples of 15 chief physicians (of 21 hospitals participating in the effectiveness trial), 60 (74) senior HPs, 65 (164) junior HPs and 187 (411) GPs.
Two-hour teaching sessions for senior HPs on a patient-centred, checklist-guided discharge routine.
Data collection on recruitment, delivery and response from chief physicians (semistructured interviews), senior HPs, junior HPs, GPs (surveys) and patients (via HPs). Quantitative data were summarised using descriptive statistics, and interviews analysed using thematic analysis.
Intervention dose (quantitative), implementation fidelity (qualitative), feasibility and acceptability, facilitators and barriers, implementation support strategies.
Recruitment of hospitals was laborious but successful, with 21 hospitals recruited. Minimal workload and a perceived benefit for the clinic were crucial factors for participation. Intervention dose was high (95% of checklist activities carried out), but intervention fidelity was limited (discharge letters) or unknown (medication review). Recruitment and retention of patients was challenging, partly due to patient characteristics (old, frail) and the COVID-19 pandemic: Only 612 of the anticipated 2100 patients were recruited, and 31% were lost to follow-up within the first month after discharge. The intervention was deemed feasible and helpful by HPs, and the relevance of the topic appreciated by both HPs and GPs.
The results from this evaluation will support interpretation of the findings of the effectiveness study and may inform researchers and policy makers who aim at improving hospital discharge.
ISRCTN18427377.
研究一项集群随机对照有效性-实施混合试验的实施情况,该试验测试了在多症状老年患者出院时进行药物审查,并在医院医生(HP)和全科医生(GP)之间进行沟通刺激,以减少再住院率的效果。
扩展 Grant 的混合方法过程评估框架,以应用于具有多层次聚类的试验。
瑞士医院的普通内科病房。
15 名首席医师(参加有效性试验的 21 家医院中的 21 名)、60 名(74 名)高级 HP、65 名(164 名)初级 HP 和 187 名(411 名)GP 的便利样本。
为高级 HP 提供两小时的教学课程,内容为以患者为中心、检查表指导的出院常规。
首席医师(半结构化访谈)、高级 HP、初级 HP、GP(调查)和患者(通过 HP)收集关于招募、交付和响应的数据。使用描述性统计对定量数据进行总结,并使用主题分析对访谈进行分析。
干预剂量(定量)、实施保真度(定性)、可行性和可接受性、促进因素和障碍、实施支持策略。
医院的招募工作虽然费力,但最终还是成功的,共招募了 21 家医院。低工作量和对诊所的感知益处是参与的关键因素。干预剂量高(开展了 95%的检查表活动),但干预保真度有限(出院信)或未知(药物审查)。招募和保留患者具有挑战性,部分原因是患者的特点(年老、体弱)和 COVID-19 大流行:预计的 2100 名患者中只有 612 名被招募,出院后第一个月内有 31%的患者失访。HP 认为干预是可行且有帮助的,HP 和 GP 都认为该主题具有相关性。
该评估的结果将支持对有效性研究结果的解释,并可能为旨在改善医院出院的研究人员和政策制定者提供信息。
ISRCTN81116523。